50% of HCC patients had elevated AFP (≥20 IU/ml) at diagnosis and within this AFP-positive cohort, 50% had elevated levels 6 months prior despite negative ultrasound imaging. This evidence concerns the gene AFP and hepatocellular carcinoma.